S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
S&P 500   4,088.85
DOW   32,654.59
QQQ   306.17
LON:MDC

Mediclinic International (MDC) Share Forecast, Price & News

GBX 352.20
-8.20 (-2.28%)
(As of 05/17/2022 12:00 AM ET)
Add
Compare
Today's Range
349.60
382
50-Day Range
337.80
393.69
52-Week Range
271.40
451.14
Volume
987,349 shs
Average Volume
646,996 shs
Market Capitalization
£2.60 billion
P/E Ratio
22.01
Dividend Yield
3.12%
Beta
N/A
30 days | 90 days | 365 days | Advanced Chart
Receive MDC News and Ratings via Email

Sign-up to receive the latest news and ratings for Mediclinic International and its competitors with MarketBeat's FREE daily newsletter.

Mediclinic International logo

About Mediclinic International

Mediclinic International plc, together with its subsidiaries, operates private hospitals. The company offers acute care, specialist-orientated, and multidisciplinary healthcare services under the Mediclinic and Hirslanden brand names. It operates 74 hospitals, 18 day case clinics, 18 outpatient clinics, 5 subacute hospitals, 2 mental health facilities, and 454 theatres with approximately 11,?449 inpatient beds in Switzerland, South Africa, Namibia, and the United Arab Emirates. The company also provides treasury, hospital equipment and procurement, emergency medical, management, food and catering, healthcare management, and debt collection and related services; manages healthcare staff; and owns and manages properties. In addition, it engages in intellectual property holding and medical store/procurement businesses. The company was founded in 1983 and is based in Stellenbosch, South Africa.

Headlines

See More Headlines

Industry, Sector and Symbol

Industry
Medical Care
Sub-Industry
N/A
Sector
Medical
CIK
N/A
Fax
N/A
Employees
30,470
Year Founded
N/A

Sales & Book Value

Annual Sales
£3.16 billion
Cash Flow
GBX 51.78 per share
Book Value
GBX 412.30 per share

Profitability

Pretax Margin
N/A

Debt

Price-To-Earnings

Miscellaneous

Free Float
N/A
Market Cap
£2.60 billion
Optionable
Optionable

Company Calendar

Today
5/18/2022
Next Earnings (Estimated)
5/25/2022

MarketRank

Overall MarketRank

1.36 out of 5 stars

Analyst Opinion: 1.5Community Rank: 3.9Dividend Strength: 0.8Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -













Mediclinic International (LON:MDC) Frequently Asked Questions

Is Mediclinic International a buy right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Mediclinic International in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Mediclinic International stock.
View analyst ratings for Mediclinic International
or view top-rated stocks.

When is Mediclinic International's next earnings date?

Mediclinic International is scheduled to release its next quarterly earnings announcement on Wednesday, May 25th 2022.
View our earnings forecast for Mediclinic International
.

What price target have analysts set for MDC?

2 brokerages have issued 1 year target prices for Mediclinic International's stock. Their forecasts range from GBX 340 to GBX 385. On average, they anticipate Mediclinic International's stock price to reach GBX 362.50 in the next twelve months. This suggests a possible upside of 2.9% from the stock's current price.
View analysts' price targets for Mediclinic International
or view top-rated stocks among Wall Street analysts.

Who are Mediclinic International's key executives?
Mediclinic International's management team includes the following people:
  • Dr. Carel Aron van der Merwe D.A. (SA), F.C.A. (SA), M.B.Ch.B., Group CEO & Exec. Director (Age 59, Pay $1.28M)
  • Mr. Petrus Jurgens Myburgh, Group CFO & Exec. Director (Age 47, Pay $890k)
  • Mr. Koert H. S. Pretorius B.Compt, MBL, Group Chief Operating Officer (Age 59)
  • Dr. Dirk C. Le Roux, Group Chief Information Officer (Age 62)
  • Mr. James Arnold, Head of Investor Relations
  • Mr. Magnus U. Oetiker, Group Chief Strategy and HR Officer (Age 50)
  • Mr. Gert C. Hattingh B.Acc. (Hons), CA(SA), Group Chief Governance Officer (Age 57)
  • Mr. Biren Valodia, Chief Marketing Officer of Medi-Clinic Southern Africa
  • Ms. Clara Findlay, Chief Legal Officer of Medicalinic Southern Africa
  • Mr. Wimpie Aucamp, Chief Operating Officer of Medi-Clinic for Southern Africa
What other stocks do shareholders of Mediclinic International own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mediclinic International investors own include Intu Properties (INTU), Capital & Counties Properties PLC (CAPC), Rdi Reit (RDI), British American Tobacco (BATS), Central Asia Metals (CAML), DRDGOLD (DRD), UK Oil & Gas (UKOG), Spire Healthcare Group (SPI), Premier Oil (PMO) and Ferrexpo (FXPO).

What is Mediclinic International's stock symbol?

Mediclinic International trades on the London Stock Exchange (LON) under the ticker symbol "MDC."

How do I buy shares of Mediclinic International?

Shares of MDC and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Mediclinic International's stock price today?

One share of MDC stock can currently be purchased for approximately GBX 352.20.

How much money does Mediclinic International make?

Mediclinic International has a market capitalization of £2.60 billion and generates £3.16 billion in revenue each year.

How many employees does Mediclinic International have?

Mediclinic International employs 30,470 workers across the globe.

What is Mediclinic International's official website?

The official website for Mediclinic International is www.mediclinic.com.

How can I contact Mediclinic International?

Mediclinic International's mailing address is 6th Floor 65 Gresham Street, LONDON, EC2V 7NQ, United Kingdom. The company can be reached via phone at +44-20-79549600.

This page was last updated on 5/18/2022 by MarketBeat.com Staff

Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.